Tamsulosin clinical trials
Also written Flomax, HIP1402 and Harnal.
How each study uses Tamsulosin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Tamsulosin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 15 Apr 1997 · FLOMAX · NDA 020579 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
153 studies that test it; most in 2021 (12)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 1998 | 3 |
| 1999 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 6 |
| 2006 | 4 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 9 |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 7 |
| 2014 | 11 |
| 2015 | 11 |
| 2016 | 6 |
| 2017 | 7 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 12 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 9 |
| 2026 | 11 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 58 · Other 97
Boehringer Ingelheim (14) · Mansoura University (8) · GlaxoSmithKline (7) · Ain Shams University (5) · Astellas Pharma Europe B.V. (5) · Hanmi Pharmaceutical Company Limited (5) · Berlin-Chemie AG Menarini Group (3) · Beni-Suef University (3)
Often tested with
Tested in the same studies.
Solifenacin (15) · Tadalafil (9) · Silodosin (7) · Mirabegron (7) · Dutasteride (6) · Finasteride (3) · HCP1303 (2) · HGP1201 (2)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 11, 3 in phase 3
Studies that test Tamsulosin, phase 3 first.
- May 2027Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related SymptomsPhase 3 · Penang Hospital, Malaysia
- Jul 2027Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum ResectionPhase 3 · CHU de Quebec-Universite Laval
- Aug 2027Efficacy and Safety of Combination Therapy Compared With Monotherapy in Patients With Benign Prostatic HyperplasiaPhase 3 · Il-Yang Pharm. Co., Ltd.
- Dec 2026Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive SurgeryPhase 2 · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
- Jan 2027Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPHNot applicable · Ain Shams University
- Jan 2027Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine SurgeryPhase 4 · Mayo Clinic
- Apr 2027Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia PatientsPhase 4 · Mohsen Pourazizi
- Apr 2027Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia PatientsPhase 4 · Mohsen Pourazizi
- Apr 2027Tamsulosin and Intraureteral Aminophylline for Ureteral Access During RIRSPhase 2 · Beni-Suef University
- May 2027Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary RetentionPhase 4 · Beni-Suef University
Studies
Open first, then newest update. How each study uses Tamsulosin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 155
- Efficacy and Safety of Combination Therapy Compared With Monotherapy in Patients With Benign Prostatic HyperplasiaNot yet recruitingPhase 3Il-Yang Pharm. Co., Ltd.NCT07870759Written as Tamsulosin 0.4Mg Capsule
- Comparison of Mirabegron and Tamsulosin for Ureteral Stone ExpulsionRecruitingPhase 4Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationNCT07310797Written as Tamsulosin
- Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum ResectionRecruitingPhase 3CHU de Quebec-Universite LavalNCT05941806Written as pr Sandoz Tamsulosin
- Post Operative Urinary Retention (POUR) Following Thoracic Oncological SurgeryRecruitingEarly Phase 1Hackensack Meridian HealthNCT05657990Written as Tamsulosin
- Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia PatientsNot yet recruitingPhase 4Mohsen PouraziziNCT07743034Written as tamsulosin 0.4mg
- Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia PatientsNot yet recruitingPhase 4Mohsen PouraziziNCT07743060Written as tamsulosin 0.4mg
- Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related SymptomsRecruitingPhase 3Penang Hospital, MalaysiaNCT06966804Written as Tamsulosin
- Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPHRecruitingNot applicableAin Shams UniversityNCT07722884Written as Tamsulosin 0.4 mg + Tadalafil 2.5 mg
- Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine SurgeryRecruitingPhase 4Mayo ClinicNCT07174349Written as Uroselective alpha-1-adrenergic receptor antagonist
- Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary RetentionRecruitingPhase 4Beni-Suef UniversityNCT07650968Written as Tamsulosin 0.4 mg
- Tamsulosin and Intraureteral Aminophylline for Ureteral Access During RIRSRecruitingPhase 2Beni-Suef UniversityNCT07623876Written as Tamsulosin
- Safety and Efficacy of Combination of Tamsulosin 0.4 mg Plus Tadalafil 5mg Versus 2.5 mgRecruitingNot applicableAin Shams UniversityNCT07562282Written as Tamsulosin
- Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive SurgeryRecruitingPhase 2Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)NCT04597372Written as Tamsulosin
- Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover TrialNot yet recruitingPhase 4Ain Shams UniversityNCT07467343Written as Tamsulosin
- Perioperative Tamsulosin for Treating Voiding Dysfunction Following Prostate BiopsyNot yet recruitingPhase 4Peking University First HospitalNCT07276919Written as Tamsulosin 0.2mg
- A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin Hydrochloride 0.4 mg, Prolonged-release Film-coated Tablets, in Healthy Adult Male Subjects, Under Fasting ConditionsRecruitingPhase 1Berlin-Chemie AG Menarini GroupNCT07156916Written as Tamsulosin (0.4 mg/j)
- Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related SymptomsRecruitingPhase 3Bir HospitalNCT06803030Written as Tamsulosin Hydrochloride 0.4 mg
- Management of Dysuria and Irritative Symptoms After HoLEP: a Prospective Study Evaluating the Efficacy of Alpha-Blocker TherapyRecruitingNot applicableAnkara Training and Research HospitalNCT06865430Written as Tamsulosin Hydrochloride
- Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology SurgeryRecruitingPhase 3TriHealth Inc.NCT06843538Written as Tamsulosin
- Efficacy and Safety of Tamsulosin for Children with Posterior Urethral Valve.RecruitingPhase 3Mansoura UniversityNCT06737016Written as Tamsulosin
See all 155 studies that test Tamsulosin →
Given beside what is tested · 17 — Tamsulosin is usual care or a partner of the new treatment
- The Effect of Acupuncture on Passing Ureteral StonesRecruitingNot applicableHitit UniversityNCT07893431Written as medical expulsive therapy (tamsulosin)
- Tamsulosin With or Without Tadalafil for Trial Without Catheter After Acute Urinary Retention Due to Benign Prostatic HyperplasiaRecruitingPhase 4Beni-Suef UniversityNCT07654413Written as Tamsulosin
- A Clinical Observation Study of a Chinese Patent Medicine Combined With Tamsulosin in Improving Sleep and Nocturia Symptoms After Enucleation of the ProstateRecruitingPhase 4The Fourth Affiliated Hospital of Zhejiang University School of MedicineNCT07357324Written as Tamsulosin Hydrochloride Sustained-Release Capsules
- Efficacy and Safety of Longidaze in the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic HyperplasiaCompletedNot applicableNPO PetrovaxNCT06568718Written as tamsulosin
- A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)CompletedPhase 4Astellas Pharma IncNCT02656173Written as Tamsulosin
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)CompletedPhase 4Astellas Pharma Global Development, Inc.NCT02757768Written as Tamsulosin Hydrochloride
- Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.Status unknownPhase 4St. Joseph's Healthcare HamiltonNCT02279615Written as Tamsulosin
- A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1801 in Healthy Male Subjects.CompletedPhase 1Hanmi Pharmaceutical Company LimitedNCT04084197Written as HIP1402
- Treatment of Symptoms After Stent Placement for Urinary Tract ObstructionCompletedPhase 4University of Wisconsin, MadisonNCT01741454Written as Tamsulosin
- Treatment of Supine Hypertension in Autonomic FailureCompletedPhase 1Vanderbilt UniversityNCT00223717Written as tamsulosin hydrochloride
- Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate HyperplasiaStatus unknownPhase 3IlDong Pharmaceutical Co LtdNCT02827578Written as Tamsulosin
- Study to Investigate the Effect of Ketoconazole Mediated CYP3A4 Inhibition on Pharmacokinetics of Tamsulosin in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02264171Written as Tamsulosin HCl
- A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.CompletedPhase 4Astellas Pharma IncNCT00333112Written as tamsulosin
- Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) PatientsStatus unknownPhase 4Seoul National University HospitalNCT01736033Written as Tamsulosin
- Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic HyperplasiaCompletedPhase 4Astellas Pharma IncNCT00771394Written as Tamsulosin hydrochloride
- Hemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and TamsulosinCompletedPhase 1VIVUS LLCNCT01100021Written as Tamsulosin and avanafil
- Efficacy Study of Tamsulosin and Tolterodine Treatment for Chronic ProstatitisStatus unknownNot applicableChongqing Medical UniversityNCT00913315Written as tamsulosin
As the comparator · 26 — what is tested is compared with Tamsulosin
- Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial)Not yet recruitingPhase 4Shanghai East HospitalNCT07846579Written as Tamsulosin hydrochloride 0.2 mg
- L-Citrulline Versus Tamsulosin for Medical Expulsive Therapy of Distal Ureteral StonesRecruitingPhase 2Beni-Suef UniversityNCT07617909Written as Tamsulosin
- Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH.RecruitingPhase 2Clinical Academic Center (2CA-Braga)NCT05401032Written as Tamsulosin
- Can Acupoint Low Intensity Shockwave Therapy Improve Bladder Voiding EfficiencyRecruitingNot applicableTaichung Armed Forces General HospitalNCT06020963Written as Tamsulosin
- The Efficacy and Safety of Silodosin in the Treatment of Benign Prostatic HyperplasiaCompletedPhase 4Xintian PharmaceuticalNCT05551221Written as Tamsulosin
- Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTSWithdrawnPhase 3Apsen Farmaceutica S.A.NCT01203371Written as Tamsulosin
- Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic HyperplasiaCompletedPhase 3EMSNCT04185441Written as Omnic Ocas
- The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPHCompletedPhase 4Shanghai Huilun Pharmaceutical Co., Ltd.NCT07134907Written as Tamsolusin
- A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate HyperplasiaCompletedPhase 2Astellas Pharma IncNCT02038868Written as Tamsulosin
- Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain SyndromeCompletedPhase 4Xintian PharmaceuticalNCT05890235Written as Tamsulosin Hydrochloride
- Silodosin vs Tamsulosin as METStatus unknownPhase 3Princess Margaret Hospital, Hong KongNCT05570084Written as Tamsulosin
- Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic HyperplasiaCompletedPhase 2/3REMD Medical TechnologyNCT05531344Written as Tamsulosin Hydrochloride Capsules
- Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPHTerminatedPhase 3RECORDATI GROUPNCT02003742Written as Tamsulosin
- Behavior and Exercise Versus Drug Treatment in Men With Nocturia (BEDTiMe)CompletedPhase 4Atlanta VA Medical CenterNCT00824200Written as tamsulosin (alpha-adrenergic antagonist medication)
- Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.CompletedPhase 1Boehringer IngelheimNCT02417831Written as tamsulosin capsules
- Efficacy and Safety of Naftopidil in Patient With Neurogenic Lower Urinary Tract Dysfunction Not Caused by Benign Prostatic HyperplasiaCompletedPhase 4Samsung Medical CenterNCT02034604Written as Tamsulosin
- Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)CompletedPhase 4Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshNCT04107896Written as Tamsulosin
- Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.CompletedPhase 2PfizerNCT00457457Written as Tamsulosin
- A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)CompletedPhase 3Eli Lilly and CompanyNCT01937871Written as 0.2 mg Tamsulosin
- Combined Behavioral and Drug Treatment of Overactive Bladder in MenCompletedPhase 2/3University of Alabama at BirminghamNCT01175382Written as Tolterodine + tamsulosin
Showing 20 of 26.
Codes
What other systems call Tamsulosin · ClinicalTrials.gg INT006718
- MeSH (NLM) D000077409TamsulosinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) G3P28OML5ITAMSULOSINConfirmed FDA, NLM, Wikidata
- RxNorm 77492Confirmed FDA, Wikidata
- Wikidata Q418480tamsulosinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75055TamsulosinOne source FDA
- DrugBank DB00706One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077409 | Tamsulosin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | G3P28OML5I | TAMSULOSIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 77492 | — | Confirmed FDA, Wikidata |
| Wikidata | Q418480 | tamsulosin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75055 | Tamsulosin | One source FDA |
| DrugBank | DB00706 | — | One source Wikidata |
Also registered as tamsulosin hydrochloride (UNII 11SV1951MR · RxNorm 236495).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.